Frontiers in Physiology (Aug 2018)

Non-invasive Stenotic Renal Artery Haemodynamics by in silico Medicine

  • Aikaterini Mandaltsi,
  • Aikaterini Mandaltsi,
  • Andrii Grytsan,
  • Andrii Grytsan,
  • Aghogho Odudu,
  • Aghogho Odudu,
  • Jacek Kadziela,
  • Paul D. Morris,
  • Paul D. Morris,
  • Paul D. Morris,
  • Adam Witkowski,
  • Timothy Ellam,
  • Philip Kalra,
  • Philip Kalra,
  • Alberto Marzo,
  • Alberto Marzo

DOI
https://doi.org/10.3389/fphys.2018.01106
Journal volume & issue
Vol. 9

Abstract

Read online

Background: Measuring the extent to which renal artery stenosis (RAS) alters renal haemodynamics may permit precision medicine by physiologically guided revascularization. This currently requires invasive intra-arterial pressure measurement with associated risks and is rarely performed. The present proof-of-concept study investigates an in silico approach that uses computational fluid dynamic (CFD) modeling to non-invasively estimate renal artery haemodynamics from routine anatomical computed tomography (CT) imaging of RAS.Methods: We evaluated 10 patients with RAS by CT angiography. Intra-arterial renal haemodynamics were invasively measured by a transducing catheter under resting and hyperaemic conditions, calculating the translesional ratio of distal to proximal pressure (Pd/Pa). The diagnostic and quantitative accuracy of the CFD-derived virtual Pd/Pa ratio (vPd/Pa) was evaluated against the invasively measured Pd/Pa ratio (mPd/Pa).Results: Hyperaemic haemodynamics was infeasible and CT angiography in 4 patients had insufficient image resolution. Resting flow data is thus reported for 7 stenosed arteries from 6 patients (one patient had bilateral RAS). The comparison showed a mean difference of 0.015 (95% confidence intervals of ± 0.08), mean absolute error of 0.064, and a Pearson correlation coefficient of 0.6, with diagnostic accuracy for a physiologically significant Pd/Pa of ≤ 0.9 at 86%.Conclusion: We describe the first in silico estimation of renal artery haemodynamics from CT angiography in patients with RAS, showing it is feasible and diagnostically accurate. This provides a methodological framework for larger prospective studies to ultimately develop non-invasive precision medicine approaches for studies and interventions of RAS and resistant hypertension.

Keywords